Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients

International Journal of Colorectal Disease

Volumn 19, Issue 6, 2004, Pages 545-553

  Sammarco, Innocenzo ^a   Capurso, Gabriele ^b   Coppola, Luigi ^c   Bonifazi, Antonio Paniccià ^c   Cassetta, Sara ^b   Delle Fave, Gianfranco ^b   Carrara, Alessandro ^c   Grassi, Giovanni Battista ^c   Rossi, Pellegrino ^a   Sette, Claudio ^a   Geremia, Raffaele ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

c KIT; Colorectal cancer; Tyrosine kinases

Indexed keywords

RNA; STEM CELL FACTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTO ONCOGENE; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 7444269880     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0601-9     Document Type: Article

References (34)

1. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E (2002) EUROPREVAL Working Group. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 13:1128-1139
2. D'Entremont TS, Sun Weijing (2003) Recent advances in colorectal cancer therapy. Cancer Biol Ther 2:6-13
3. Traxler P (2003) Tyrosine kinases as targets in cancer therapy - successes and failures. Expert Opin Ther Targets 7:215-234
4. Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692-1703
5. Besmer P, Manova K, Duttlinger R, et al (1993) The kit-ligand (steel factor) and its receptor c-KIT/W: pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl 125-137
6. Hassan HT, Zander A (1996) Stem cell factor as survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol 95:257-262
7. Ricotti E, Fagioli F, Garelli, E, et al (1998) C-KIT is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood 91:2397-2405
8. Huang S, Luca M, Gutman M, et al (1996) Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 13:2339-2347
9. He J, deCastro CM, Vandenbark GR, Busciglio J, Gabuzda D (1997) Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc Nad Acad Sci USA 94:3954-3959
10. Bellone G, Silvestri S, Artusio E, et al (1997) Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-β1. J Cell Physiol 172:1-11
11. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A (1992) Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139-6143
12. Matsuda R, Takahashi T, Nakamura S, et al (1993) Expression of the c-kit protein in human solid tumours and in corresponding fetal and adult normal tissues. Am J Pathol 142:339-346
13. Reed J, Ouban A, Schickor FK, Muraca P, Yeatman T, Coppola D (2002) Immunohistochemical staining for c-kit (CD117) is a rare event in human colorectal carcinoma. Clin Colorectal Cancer 2:119-122
14. Manley PW, Cowan-Jacob SW, Buchdunger E, et al (2002) Imatinib a selective tyrosine kinase inhibitor. Eur J Cancer 38: S19-S27
15. Druker BJ, Sawyers CL, Kantarjian H, et al (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038-1042
16. Dagher R, Cohen M, Williams G, et a] (2002) Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 8:3034-3038
17. Esposito I, Kleeff J, Bischoff SC, et al (2002) The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 82:1481-1492
18. Fjallskog ML, Lejonklou MH, Oberg KE, Eriksson BK, Janson ET (2003) Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin Cancer Res 9:1469-1473
19. Hibi K, Takahashi T, Sekido Y, et al (1991) Coexpression of the stem cell factor and the c-kit genes in small cell lung cancer. Oncogene 6:2291-2296
20. Timeus F, Crescenzio N, Valle P, et al (1997) Stem cell factor suppress apoptosis in neuroblastoma cell lines. Exp Hematol 25:1253-1260
21. Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A (1992) Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 52:713-717
22. Natali PG, Berlingieri MT, Nicotra MR, et al (1995) Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res 55:1787-1791
23. Tonary AM, McDonald EA, Faugh W, Senterman MK, Vanderhyden BC (2000) Lack of expression of c-kit in ovarian cancers is associated with poor prognosis. Int J Cancer 89:242-250
24. Burger H, den Bakker MA, Stoter G, Verweij J, Nooter K (2003) Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens. Eur J Cancer 39:793-799
25. Lyford GL, He C-L, Soffer E, et al, (2002) Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 51:496-501
26. Hornick JL, Fletcher CD, (2003) Validating immunohistochemical staining for KIT (CD117). Am J Clin Pathol 119:325-327
27. Toyota M, Hinoda Y, Itoh F, Takaoka A, Imai K, Yachi A (1994) Complementary DNA cloning of truncated form of c-kit in human colon carcinoma cells. Cancer Res 54: 272-275
28. Takaoka A, Toyota M, Hinoda Y, Itoh F, Mita H, Kakiuchi H, Adachi M, Imai K (1997) Expression and identification of aberrant c-kit transcripts in human cancer cells. Cancer Lett 115:257-261
29. Rossi P, Marziali G, Albanesi C, Charlesworth A, Geremia R, Sorrentino V (1992) A novel c-kit transcript, potentially encoding a truncated receptor, originates within a kit gene intron in mouse spermatids. Dev Biol 152:203-207
30. Sette C, Paronetto MP, Barchi M, Bevilacqua A, Geremia R, Rossi P (2002) Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase. EMBO J 21:5386-5395
31. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21:187-190
32. Windham TC, Parikh NU, Siwak DR, Summy JM, McConkey DJ, Kraker AJ, Gallick GE (2002) Src activation regulates anoikis in human colon tumor cell lines. Oncogene 21:7797-7807
33. Shawer L, Slamon D, Ullrich A (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1: 117-123
34. Attoub S, Rivat C, Rodrigues S, et al (2002) The c-kit tyrosine kinase inhibitor ST1571 for colorectal cancer therapy. Cancer Res 62:4879-4883